4/15
08:00 am
cue
Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026
High
Report
Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026
4/8
08:00 am
cue
Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement
High
Report
Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement
4/7
05:05 pm
cue
Cue Biopharma, Inc. (CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases Transcript [Seeking Alpha]
High
Report
Cue Biopharma, Inc. (CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases Transcript [Seeking Alpha]
3/27
05:06 pm
cue
Cue Biopharma Announces CEO Transition [Yahoo! Finance]
Low
Report
Cue Biopharma Announces CEO Transition [Yahoo! Finance]
3/27
04:26 pm
cue
Cue Biopharma Announces CEO Transition [TheStreet.com]
Low
Report
Cue Biopharma Announces CEO Transition [TheStreet.com]
3/27
04:05 pm
cue
Cue Biopharma Announces CEO Transition
Medium
Report
Cue Biopharma Announces CEO Transition
3/26
08:41 am
cue
Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026 [Yahoo! Finance]
Low
Report
Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026 [Yahoo! Finance]
3/26
08:00 am
cue
Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026
Low
Report
Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026
3/16
04:33 pm
cue
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights [Yahoo! Finance]
High
Report
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights [Yahoo! Finance]
3/16
04:05 pm
cue
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
High
Report
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
3/9
08:13 am
cue
Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026 [Yahoo! Finance]
Low
Report
Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026 [Yahoo! Finance]
3/9
08:00 am
cue
Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026
Low
Report
Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026
2/17
08:00 am
cue
Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases
Low
Report
Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases
2/12
08:00 am
cue
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer
Medium
Report
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer